Sedaconda (isoflurane)
Sedaconda (isoflurane)
Sedaconda is indicated for sedation of mechanically ventilated adult patients during intensive care.
Sedaconda is today approved in Austria*, Belgium, Croatia, Denmark, Finland, France*, Germany, Ireland, Netherlands, Norway, Poland, Portugal, Slovenia, Spain, Sweden, Switzerland, and United Kingdom.
*In Austria and France, the treatment will be marketed under the brand name Cedaconda.
We cannot provide detailed information about our prescription medicines on this website, in compliance with regulations.